Physician
Infectious Disease
Dr. Michael L. Zeckel, MD
|
|
Give Review
Michael Zeckel works in the field of Infectious Disease. Michael L. Zeckel, MD has written publications. He has 21 publications published with PubMed. The lastest publication is: 'Cefaclor and cefuroxime axetil in the treatment of otitis media--an alternative view.'
Publications
- Pharmacodynamics of oritavancin (LY333328) in a neutropenic-mouse thigh model of Staphylococcus aureus infection.
- Histoplasmosis in the acquired immune deficiency syndrome.
- Disseminated histoplasmosis in the acquired immune deficiency syndrome: clinical findings, diagnosis and treatment, and review of the literature.
- Loracarbef (LY163892) in the treatment of acute exacerbations of chronic bronchitis: results of U.S. and European comparative clinical trials.
- Pharmacokinetic profile of loracarbef.
- Loracarbef (LY163892) versus amoxicillin/clavulanate in the treatment of acute bacterial exacerbations of chronic bronchitis.
- Parameters affecting the enzyme-linked immunosorbent assay of immunoglobulin G antibody to a rough mutant of Salmonella minnesota.
- Lack of correlation between killing of gonococci by serum and antibodies directed against pili from strain 2686 of Neisseria gonorrhoeae.
- In vitro activities of LY333328 and comparative agents against nosocomial gram-positive pathogens collected in a 1997 global surveillance study.
- Cefaclor and cefuroxime axetil in the treatment of otitis media--an alternative view.
- [The 3rd Japanese-United States Vancomycin Forum].
- A closer look at vancomycin, teicoplanin, and antimicrobial resistance.
- Beyond vancomycin: new therapies to meet the challenge of glycopeptide resistance.
- Penetration of loracarbef into the maxillary sinus: a pharmacokinetic assessment.
- Twice-daily dosing of loracarbef 200 mg versus 400 mg in the treatment of patients with acute maxillary sinusitis.
- Radioimmunoassay for detection of IgG antibodies against enterobacterial antigens.
- Prophylactic antibiotics in surgery.
- Daptomycin: a novel agent for Gram-positive infections.
- Risk of hepatic events in patients treated with vancomycin in clinical studies: a systematic review and meta-analysis.
- A retrospective observational study of drotrecogin alfa (activated) in adults with severe sepsis: comparison with a controlled clinical trial.
Schools
Indiana University School of Medicine
Doctors Specialties
- Infectious Disease Medicine
- Infectious Disease
Accepted Insurances
Helpful Reviews
Similar Doctors
|
|
Dr. Timothy R. Franson, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Victoria M. Venturella, FNP-BC
This Doctor is OpenDoctor Recommended.
|